SIGNIFICANCE OF RELAPSE FOLLOWING ADJUVANT THERAPY WITH CMF OR 5-FU IN HIGH-RISK BREAST-CANCER

被引：0
|
作者：
CHLEBOWSKI, RT [1 ]
WEINER, JM [1 ]
LUCE, J [1 ]
HESTORFF, R [1 ]
LANG, JE [1 ]
REYNOLDS, R [1 ]
GODFREY, T [1 ]
RYDEN, VMJ [1 ]
BATEMAN, JR [1 ]
机构：
[1] WESTERN CANC STUDY GRP,LOS ANGELES,CA 90509
来源：
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH | 1981年 / 22卷 / MAR期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：146 / 146
页数：1
相关论文
共 50 条
  • [21] ADJUVANT SYSTEMIC THERAPY FOR BREAST-CANCER - A TALE OF RELAPSE AND SURVIVAL
    PRITCHARD, KI
    LANCET, 1994, 343 (8894): : 370 - 371
  • [22] ADJUVANT CHEMOTHERAPY FOR BREAST-CANCER WITH 3 OR 5 DRUGS, CMF VS CMFVP
    HOLLAND, JF
    TORMEY, D
    WEINBERG, V
    WEISS, R
    LESNICK, G
    GLIDEWELL, O
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR): : 386 - 386
  • [23] ANTICIPATORY VOMITING IN WOMEN RECEIVING CYCLOPHOSPHAMIDE, METHOTREXATE, AND 5-FU (CMF) ADJUVANT CHEMOTHERAPY FOR BREAST-CARCINOMA
    WILCOX, PM
    FETTING, JH
    NETTESHEIM, KM
    ABELOFF, MD
    CANCER TREATMENT REPORTS, 1982, 66 (08): : 1601 - 1604
  • [24] ADJUVANT CHEMOTHERAPY WITH 5-FLUOROURACIL (5-FU) OR 5-FU PLUS METHYL-CCNU FOLLOWING SURGERY IN COLONIC CANCER
    DEXEUS, FA
    THIRLWELL, MP
    MACFARLANE, JK
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1978, 19 (MAR): : 367 - 367
  • [25] THERAPY OF ADVANCED (METASTASIZED OR WITH HIGH-RISK FOR METASTASES) BREAST-CANCER
    HAYAT, M
    DROZ, JP
    BULLETIN DU CANCER, 1989, 76 (01) : 63 - 64
  • [26] TAMOXIFEN RECHALLENGE - RESPONSE TO TAMOXIFEN FOLLOWING RELAPSE AFTER ADJUVANT CHEMOHORMONAL THERAPY FOR BREAST-CANCER
    MUSS, HB
    SMITH, LR
    COOPER, MR
    JOURNAL OF CLINICAL ONCOLOGY, 1987, 5 (10) : 1556 - 1558
  • [27] ESTROGEN-RECEPTOR STATUS AND ADJUVANT POLYCHEMOTHERAPY OR ANTIESTROGEN THERAPY IN PATIENTS WITH HIGH-RISK BREAST-CANCER
    JONAT, W
    MAASS, H
    BRAUN, M
    WINTER, G
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1984, 107 (03) : 233 - 237
  • [28] Adjuvant chemotherapy of patients with primary breast cancer (PABC) by fluorouracil (5-FU)
    Hazova, TV
    Koritova, LI
    Ilyin, NV
    EUROPEAN JOURNAL OF CANCER, 1998, 34 : S32 - S32
  • [29] COHORT OF HIGH-RISK BREAST-CANCER PATIENTS RECEIVING 5 DRUG ADJUVANT CHEMOTHERAPY WITH OR WITHOUT RADIOTHERAPY
    CAREY, RW
    KAUFMAN, S
    SOHIER, WD
    KELLEY, RM
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1977, 18 (MAR): : 287 - 287
  • [30] REEVALUATION OF THE INDICATIONS OF ADJUVANT HORMONOTHERAPY IN HIGH-RISK PRIMARY BREAST-CANCER PATIENTS
    MARTIN, PM
    ROMAIN, S
    SPYRATOS, F
    SPITALIER, JM
    AYME, Y
    BRANDONE, H
    BRESSAC, C
    HANS, D
    JACQUEMIER, J
    HACENE, K
    BRUNET, M
    AMALRIC, R
    BULLETIN DU CANCER, 1991, 78 (08) : 709 - 723
12345